Jagsonpal Pharmaceuticals Ltd. (JAGSNPHARM): Jagsonpal Pharmaceuticals Share Price Rises 9.87% Today
- September 24, 2026
- Posted by: Harsh Piplani
- Category: News
Jagsonpal Pharmaceuticals Share Price moved higher on 24 September 2026, with the stock closing at Rs 248.20 after rising 9.87% from the previous close of Rs 225.90. The company’s market capitalisation stands at Rs 1,489.98 crore, putting the day’s move into clear size context for investors tracking Jagsonpal Pharmaceuticals Share Price Today and Jagsonpal Pharmaceuticals Stock News.
The session opened at Rs 230.05, matched the day’s low at Rs 230.05, and reached a high of Rs 249.00 before settling near the upper end of the range. The data confirms a same-day price rise, but it does not establish a company-specific catalyst. For readers following Jagsonpal Pharmaceuticals Share Price, the key takeaway is straightforward: the move is measurable, the valuation is visible, and the healthcare sector backdrop is available for comparison on Univest.
In market terms, this was a notable share price gain and one of the cleaner Jagsonpal Pharmaceuticals Stock Gaining Today events in the current session. The verified numbers also make it useful for search intent around Jagsonpal Pharmaceuticals Share Price Today, Jagsonpal Pharmaceuticals Share Price Update and Jagsonpal Pharmaceuticals Stock Analysis. On Univest, the next step for investors is to place the move alongside fundamentals, valuation and peer positioning rather than reading more into the day’s rise than the supplied data supports.
Jagsonpal Pharmaceuticals Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 248.2 |
| Previous Close | Rs 225.9 |
| Today's Move | Rs 22.3 (+9.87%) |
| Open | Rs 230.05 |
| High | Rs 249 |
| Low | Rs 230.05 |
| Turnover | Rs 7.45 crore |
| Market Capitalisation | Rs 1,489.98 crore |
| Market Cap Category | Small Cap |
Jagsonpal Pharmaceuticals Ltd. (JAGSNPHARM) rose to Rs 248.2 from the previous close of Rs 225.9, a move of Rs 22.3 or 9.87%. The stock opened at Rs 230.05, reached a high of Rs 249, recorded a low of Rs 230.05.
Jagsonpal Pharmaceuticals Share Price today moved from a previous close of Rs 225.90 to Rs 248.20, a gain of Rs 22.30 or 9.87%. The stock traded between Rs 230.05 and Rs 249.00 during the session, which shows that the day’s high was very close to the closing price. Turnover for the day stood at Rs 7.45 crore. These figures confirm a strong same-day price rise without adding any unverified explanation. The event is relevant because the move was large enough to stand out in Stocks in News and Top Gainers Today searches, while still remaining a factual price action update rather than a narrative about cause.
Jagsonpal Pharmaceuticals Ltd. (JAGSNPHARM) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 1,489.98 crore |
| P/E Ratio | 32.76x |
| P/B Ratio | 6.47x |
| ROE | 18.19% |
| ROCE | 22.69% |
| EPS | Rs 6.89 |
| Book Value Per Share | Rs 34.91 |
| Dividend Yield | 2.43% |
Jagsonpal Pharmaceuticals Ltd. (JAGSNPHARM) fundamental metrics show P/E 32.76x, P/B 6.47x, ROE 18.19%, ROCE 22.69%. These figures provide context only and are not a buy or sell signal.
Jagsonpal Pharmaceuticals Ltd. has a market capitalisation of Rs 1489.98 crore and falls in the Small Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 32.76x, P/B at 6.47x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 18.19% and ROCE of 22.69%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 6.89, book value per share of Rs 34.91, dividend yield of 2.43%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 31.9x, median ROE of 11.7%, median ROCE of 13.46%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 32.76x |
| Benchmark Median P/E | 31.9x |
| Benchmark Average P/E | 50.01x |
| Benchmark P/E Range | 3.48x to 762.66x |
| Company P/B Ratio | 6.47x |
| Benchmark Median P/B | 3x |
| Company ROE | 18.19% |
| Benchmark Median ROE | 11.7% |
| Company ROCE | 22.69% |
| Benchmark Median ROCE | 13.46% |
| Company Market Capitalisation | Rs 1,489.98 crore |
| Benchmark Median Market Cap | Rs 761.61 crore |
Jagsonpal Pharmaceuticals Ltd. (JAGSNPHARM) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Jagsonpal Pharmaceuticals Ltd. (JAGSNPHARM) has a P/E ratio of 32.76x, which is above the benchmark median of 31.9x, a difference of +2.7%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Jagsonpal Pharmaceuticals Ltd. (JAGSNPHARM) has a ROE of 18.19%, which is above the benchmark median of 11.7%, a difference of +55.47%. Jagsonpal Pharmaceuticals Ltd. (JAGSNPHARM) has a ROCE of 22.69%, which is above the benchmark median of 13.46%, a difference of +68.57%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,42,437.37 | 37 | 5.17 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,48,053.84 | 87.1 | 14.42 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,89,841.6 | 86.85 | 21.1 | 26.76 | 19.27 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,15,810.19 | 25.85 | 4.33 | 19.69 | 21.39 |
| Cipla Ltd. | CIPLA | 1,11,565.25 | 33.08 | 3.17 | 11.83 | 16 |
Jagsonpal Pharmaceuticals Ltd. (JAGSNPHARM) has a P/E ratio of 32.76x compared with the displayed peer median of 37x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 18.19% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 22.69% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Jagsonpal Pharmaceuticals Ltd. (JAGSNPHARM) has a market capitalisation of Rs 1,489.98 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching Jagsonpal Pharmaceuticals
- Jagsonpal Pharmaceuticals Share Price rose 9.87% today to Rs 248.20, with the day’s high at Rs 249.00.
- The stock’s market capitalisation is Rs 1,489.98 crore, which places the move in a clearly defined company size band.
- P/E is 32.76 and P/B is 6.47, so Jagsonpal Pharmaceuticals Share Price is being read through both earnings and book-value multiples.
- ROE stands at 18.19% and ROCE at 22.69%, giving the stock return ratios above the sector median in the supplied benchmark.
- Sector context matters: the company belongs to Healthcare and Pharmaceuticals & Drugs, with peer comparison data available on Univest.
About Jagsonpal Pharmaceuticals
Jagsonpal Pharmaceuticals Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. Based on the supplied company context, it is positioned as a listed pharmaceutical business whose market data can be reviewed on NSE and BSE through Jagsonpal Pharmaceuticals Share Price pages. The company’s profile is best understood through its financial ratios, market capitalisation and peer set rather than through any unsupported narrative about a single-day move.
For readers following Jagsonpal Pharmaceuticals Share Price, the business context matters because pharmaceuticals are often assessed through earnings quality, balance-sheet value, return ratios and relative valuation. The company’s current P/E of 32.76, P/B of 6.47, ROE of 18.19% and ROCE of 22.69% provide a concise fundamental picture. Jagsonpal Pharmaceuticals Stock News on Univest can therefore be read as a combination of market action and company quality indicators, not as a standalone headline. That is also why Jagsonpal Pharmaceuticals Share Price Today is best tracked alongside industry peers and sector benchmarks.
Track Jagsonpal Pharmaceuticals Share Price on Univest
Use Jagsonpal Pharmaceuticals Ltd. (JAGSNPHARM) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why did Jagsonpal Pharmaceuticals Share Price rise today?
Ans. The supplied data confirms a same-day price rise of 9.87% to Rs 248.20, but it does not establish a company-specific catalyst. Readers can still use the move, turnover and valuation data for Jagsonpal Pharmaceuticals Share Price analysis.
What is Jagsonpal Pharmaceuticals Share Price today?
Ans. Jagsonpal Pharmaceuticals Share Price today is Rs 248.20. It rose from the previous close of Rs 225.90, adding Rs 22.30 during the session and placing the stock near its intraday high of Rs 249.00.
What is the market capitalisation of Jagsonpal Pharmaceuticals?
Ans. Jagsonpal Pharmaceuticals has a market capitalisation of Rs 1,489.98 crore. That figure helps place Jagsonpal Pharmaceuticals Share Price in context when comparing it with the broader Healthcare sector and selected pharmaceuticals peers.
Is Jagsonpal Pharmaceuticals expensive on valuation?
Ans. Jagsonpal Pharmaceuticals Share Price carries a P/E of 32.76 and a P/B of 6.47. The stock trades above the sector median on both ratios, while ROE and ROCE remain above the benchmark medians.
How does Jagsonpal Pharmaceuticals compare with peers?
Ans. Jagsonpal Pharmaceuticals Share Price has a smaller market capitalisation than major peers such as Sun Pharmaceutical, Divi’s Laboratories and Torrent Pharmaceuticals, but its return ratios are competitive and its valuation sits closer to several listed healthcare names.
What does EPS tell investors about Jagsonpal Pharmaceuticals?
Ans. EPS for Jagsonpal Pharmaceuticals is Rs 6.89. For Jagsonpal Pharmaceuticals Share Price, that means each share is backed by a stated earnings figure that investors can compare with the current market price and valuation multiples.
What is the dividend yield for Jagsonpal Pharmaceuticals Share Price?
Ans. The dividend yield is 2.43%. This is a factual income measure for Jagsonpal Pharmaceuticals Share Price and should be read as historical or current payout data, not as a guaranteed future distribution.
Where can investors track Jagsonpal Pharmaceuticals Share Price live?
Ans. Investors can track Jagsonpal Pharmaceuticals Share Price live on Univest, where price data, fundamentals, sector context and peer comparison are arranged together for quicker review of Jagsonpal Pharmaceuticals Stock News and share price movement.
